Imperial College Reports Preliminary Psilocybin Signals in Anorexia Nervosa Treatment

Imperial College London has announced preliminary findings from a pilot study investigating psilocybin as a potential treatment for anorexia nervosa, showing initial improvements in patients. However, researchers emphasize that results come from a small sample size and stress important safety considerations. This early-stage research adds to growing evidence exploring psychedelic-assisted therapies for severe eating disorders that have historically shown limited treatment options. The findings warrant further investigation through larger, controlled clinical trials to establish efficacy and safety protocols. These results represent a significant step in expanding therapeutic approaches for one of the most challenging psychiatric conditions.